过去10年的努力，西方国家乳腺癌死亡率已开始下降，但转移性乳腺癌（MBC）的临床结果仍很差。MBC主要治疗目的是延长生存时间，标准一线化疗使用蒽环类或紫杉类药物，但经常出现耐药，因此需要新治疗进一步...
Over the past 10 years of efforts, the Western countries have started to decline in breast cancer mortality, but metastatic breast cancer (MBC) clinical results are still poor. MBC main purpose is to extend the survival time of treatment, the standard first-line chemotherapy using anthracycline or taxane drugs, but often resistant, requiring new treatment further ...
